✦ LIBER ✦

Offering participants results of a clinical trial: sharing results of a negative study

✍ Scribed by Ann H Partridge; Julia S Wong; Katherine Knudsen; Rebecca Gelman; Ebonie Sampson; Michele Gadd; Karyn L Bishop; Jay R Harris; Eric P Winer

Book ID: 117291081
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 60 KB
Volume: 365
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)71085-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Offering participants results of a clini

Offering participants results of a clinical trial: sharing results of a negative study

✍ A.H. Partridge; J.S. Wong; K. Knudsen; R. Gelman; E. Sampson; M. Gadd; K.L. Bish 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

The impact of sharing results of a rando

The impact of sharing results of a randomized breast cancer clinical trial with study participants

✍ Ann H. Partridge; A. C. Wolff; P. K. Marcom; P. A. Kaufman; L. Zhang; R. Gelman; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 262 KB

Participants’ uptake of clinical trial r

Participants’ uptake of clinical trial results: a randomised experiment

✍ Mancini, J; Genre, D; Dalenc, F; Ferrero, J-M; Kerbrat, P; Martin, A-L; Roché, H 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 251 KB

Interpreting results of a “negative” stu

Interpreting results of a “negative” study

✍ E. O'Brian Smith 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Clinical trials, reviews, and the Journa

Clinical trials, reviews, and the Journal of Negative Results.

✍ C Maxwell 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Generalizability of cancer clinical tria

Generalizability of cancer clinical trial results : Prognostic differences between participants and nonparticipants

✍ Linda S. Elting; Catherine Cooksley; B. Nebiyou Bekele; Michael Frumovitz; Eleni 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

## Abstract ## BACKGROUND The generalizability of clinical trial results is questionable, because fewer than 5% of cancer patients participate. The authors examined the comparability of clinical trial participants and nonparticipants and the potential impact of differences. ## METHODS A retrospe